You experienced vomiting more than twice in the past week
Prof Barbara McGowan, a consultant endocrinologist who co-authored a Novo Nordisk-funded study which trialled semaglutide to treat obesity, says licensed medications - like Ozempic and Wegovy - go through "very strict" quality controls before they are approved for use
In the SUSTAIN6 trial, semaglutide (a GLP-1RA) significantly increased diabetic retinopathy complications, including vitreous hemorrhage [2], while a recent retrospective cohort study of patients with type 2 diabetes showed that use of GLP-1RAs modestly increased the incident risk of diabetic retinopathy, although sight-threatening diabetic complications including blindness were somewhat lower in patients treated with GLP-1 RAs [5]
doi: 10.1155/2024/3985731 82 HirschC.TegtmeyerN.RohdeM.RowlandM.OyarzabalO
During your consultation, our team will review your medical history and determine the safest, most effective way for you to begin
The inflammatory factors associated with disease severity to predict COVID-19 progression
